1246184-55-3

Basic information

• Product Name: 7-BroMo-3-iodo-iMidazo[1,2-a]pyridine
• Synonyms: 7-BroMo-3-iodo-iMidazo[1,2-a]pyridine;7-bromo-3-iodoH-imidazo[1,2-a]pyridine
• CAS NO: 1246184-55-3
• Molecular Formula: C₇H₄BrIN₂
• Molecular Weight: 322.92853
• EINECS: -0
• Mol File: 1246184-55-3.mol
• Article Data: 6

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 7-BroMo-3-iodo-iMidazo[1,2-a]pyridine(CAS DataBase Reference)
• NIST Chemistry Reference: 7-BroMo-3-iodo-iMidazo[1,2-a]pyridine(1246184-55-3)
• EPA Substance Registry System: 7-BroMo-3-iodo-iMidazo[1,2-a]pyridine(1246184-55-3)

Safety Data

• Hazardous Substances Data: 1246184-55-3(Hazardous Substances Data)

Usage

General Description

7-Bromo-3-iodo-Imidazo[1,2-a]pyridine is a chemical compound with the molecular formula C7H4BrIN2. It is a heterocyclic organic compound with a fused imidazo[1,2-a]pyridine ring system. This chemical is a potential precursor for the synthesis of various pharmaceutical compounds and research chemicals. It has been investigated for its potential use in the development of new drugs, particularly in the field of medicinal chemistry. The chemical properties and structure of 7-Bromo-3-iodo-Imidazo[1,2-a]pyridine make it a valuable building block for the synthesis of novel and complex molecules.

Upstream product

• 84249-14-9 2-amino-4-bromopyridine 
• 808744-34-5 7-bromoimidazo[1,2-a]pyridine 

Relevant articles and documents

MDM2 DEGRADERS AND USES THEREOF

The present invention relates to compounds and methods useful for the modulation of mouse double minute 2 homolog ("MDM2") protein via ubiquitination and/or degradation by compounds according to the present invention.

NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF DISEASES

The present invention discloses compounds according to Formula (I), wherein R1a, R1b, R1c, R2a, W1, W2, X1, X2, X3, Y, and Z are as defined herein. The present invention relates to compounds, methods for their production, pharmaceutical compositions comprising the same, and methods of treatment using the same, for the prophylaxis and/or treatment of inflammatory diseases, autoinflammatory diseases, autoimmune diseases, proliferative diseases, fibrotic diseases, transplantation rejection, diseases involving impairment of cartilage turnover, congenital cartilage malformation, diseases involving impairment of bone turnover, diseases associated with hypersecretion of IL-6, diseases associated with hypersecretion of TNFα, interferons, IL-12 and/or IL-23, respiratory diseases, endocrine and/or metabolic diseases, cardiovascular diseases, dermatological diseases, and/or abnormal angiogenesis associated diseases by administering the compound of the invention.

Substituted heteroaryl compounds and compositions and uses thereof (by machine translation)

The invention discloses substituted heteroaryl compounds and compositions thereof and their use. The compounds of formula (I) compound or type shown in (I) a compound represented by stereo isomers, tautomers, nitrogen oxide, solvate, metabolite, pharmaceutically acceptable salt or its prodrug. The invention also provides a pharmaceutical composition, the compounds and pharmaceutical compositions can be regulated protein kinase, particularly Aurora kinase and JAK kinase activity, for the prevention, treatment, treatment and reduce protein kinase, in particular JAK kinase activity mediated diseases or disorders. (by machine translation)